C. González

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

E A Emini, D. Richman, D. Havlir, 1997, The New England journal of medicine.

Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.

A. Fulgenzi, D. Palmero, C. González, 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Longitudinal assessment of nutritional status in children treated for acute lymphoblastic leukaemia in Cuba.

C. González, A. González, L. Cortina, 2004, European journal of cancer.

Editorial 44.pmd

B. Gazzard, Z. Fox, P. Vernazza, 2005 .

Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.

X. Aguilera, I. Delgado, J. Hormázabal, 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up.

D. Richman, D. Havlir, J. Mellors, 1998, JAMA.

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

W. Borkowsky, Mimi Kim, S. Chandwani, 1999, AIDS.

Differential characteristics of HIV-infected penitentiary patients and HIV-infected community patients

E. Bouza, J. Pérez-Molina, C. González, 2002, HIV clinical trials.

Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma

M. Ferracin, M. Fabbri, G. Calin, 2014, Cell Death and Disease.

Impact of changes in the treatment of nasopharyngeal carcinoma: an experience of 30 years.

P. Cuesta, C. González, I. de la Fuente, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

Cameron K. Murray, Glenda F. Brown, Patrick B. Dorr, 2023, JAMA.